{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:45:44Z","timestamp":1789969544824,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T00:00:00Z","timestamp":1508803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T00:00:00Z","timestamp":1508803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Systemic Lupus Erythematosus (SLE) and pemphigus are two representative autoimmune diseases driven by pathogenic autoantibody systemically and organ-specifically, respectively. Given the involvement of antibody in the pathogenesis, B cells are inclined to differentiate and function in an abnormal activation model. Here we defined a unique CD19\n                    <jats:sup>hi<\/jats:sup>\n                    B cell population existing in the periphery of SLE and pemphigus patients as well as in human tonsils. CD19\n                    <jats:sup>hi<\/jats:sup>\n                    B cells could be induced\n                    <jats:italic>in vitro<\/jats:italic>\n                    after co-culturing fully activated CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells with autologous B cells. They expressed high levels of HLA-DR, IgG, IgM and multiple ligands of costimulatory molecules with the capacity to produce extra IgG and IgM. Transcirptome assay revealed that genes involved in B-cell activation and differentiation were up-regulated in CD19\n                    <jats:sup>hi<\/jats:sup>\n                    B cells. Antibody blockade experiments showed that the interactions between costimulatory molecules contributed to CD19\n                    <jats:sup>hi<\/jats:sup>\n                    B-cell generation and IgG\/IgM production. What is more, frequencies of peripheral CD19\n                    <jats:sup>hi<\/jats:sup>\n                    B cells from SLE and pemphigus patients were correlated with serum total IgG and IgM, but not with autoantigen-specific antibodies and disease severity. Therefore, our investigation demonstrates that CD19\n                    <jats:sup>hi<\/jats:sup>\n                    B cells might contain B cell precursors for terminal differentiation and contribute to total IgG\/IgM production in human autoimmune diseases.\n                  <\/jats:p>","DOI":"10.1038\/s41598-017-14089-2","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T07:31:52Z","timestamp":1508311912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Peripheral CD19hi B cells exhibit activated phenotype and functionality in promoting IgG and IgM production in human autoimmune diseases"],"prefix":"10.1038","volume":"7","author":[{"given":"Zhicui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,24]]},"reference":[{"key":"14089_CR1","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.coi.2012.10.004","volume":"24","author":"J Choi","year":"2012","unstructured":"Choi, J., Kim, S. T. & Craft, J. The pathogenesis of systemic lupus erythematosus-an update. Curr Opin Immunol \n                           24, 651\u2013657 (2012).","journal-title":"Curr Opin Immunol"},{"key":"14089_CR2","unstructured":"Amagai, M. Pemphigus: autoimmunity to epidermal cell adhesion molecules. Adv Dermatol \n                           11, 319\u2013352; discussion 353 (1996)."},{"key":"14089_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4103\/0378-6323.60558","volume":"76","author":"VD Pradhan","year":"2010","unstructured":"Pradhan, V. D., Patwardhan, M. M. & Ghosh, K. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies. Indian J Dermatol Venereol Leprol \n                           76, 145\u2013149 (2010).","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"14089_CR4","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1159\/000056375","volume":"14","author":"M Hertl","year":"2001","unstructured":"Hertl, M. & Veldman, C. Pemphigus\u2013paradigm of autoantibody-mediated autoimmunity. Skin Pharmacol Appl Skin Physiol \n                           14, 408\u2013418 (2001).","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"key":"14089_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.it.2007.10.005","volume":"29","author":"S Roulland","year":"2008","unstructured":"Roulland, S., Suarez, F., Hermine, O. & Nadel, B. Pathophysiological aspects of memory B-cell development. Trends Immunol \n                           29, 25\u201333 (2008).","journal-title":"Trends Immunol"},{"key":"14089_CR6","doi-asserted-by":"publisher","first-page":"5905","DOI":"10.1073\/pnas.0601502103","volume":"103","author":"MC Hsu","year":"2006","unstructured":"Hsu, M. C., Toellner, K. M., Vinuesa, C. G. & Maclennan, I. C. B cell clones that sustain long-term plasmablast growth in T-independent extrafollicular antibody responses. Proc Natl Acad Sci USA \n                           103, 5905\u20135910 (2006).","journal-title":"Proc Natl Acad Sci USA"},{"key":"14089_CR7","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/nri1714","volume":"5","author":"CG Vinuesa","year":"2005","unstructured":"Vinuesa, C. G., Tangye, S. G., Moser, B. & Mackay, C. R. Follicular B helper T cells in antibody responses and autoimmunity. Nat Rev Immunol \n                           5, 853\u2013865 (2005).","journal-title":"Nat Rev Immunol"},{"key":"14089_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1146\/annurev.iy.12.040194.001001","volume":"12","author":"IC MacLennan","year":"1994","unstructured":"MacLennan, I. C. Germinal centers. Annu Rev Immunol \n                           12, 117\u2013139 (1994).","journal-title":"Annu Rev Immunol"},{"key":"14089_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1600-065X.2012.01124.x","volume":"247","author":"MJ Shlomchik","year":"2012","unstructured":"Shlomchik, M. J. & Weisel, F. Germinal center selection and the development of memory B and plasma cells. Immunol Rev \n                           247, 52\u201363 (2012).","journal-title":"Immunol Rev"},{"key":"14089_CR10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.immuni.2016.02.012","volume":"44","author":"M Menon","year":"2016","unstructured":"Menon, M., Blair, P. A., Isenberg, D. A. & Mauri, C. A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus. Immunity \n                           44, 683\u2013697 (2016).","journal-title":"Immunity"},{"key":"14089_CR11","doi-asserted-by":"publisher","first-page":"254245","DOI":"10.1155\/2015\/254245","volume":"2015","author":"Z Vadasz","year":"2015","unstructured":"Vadasz, Z. et al. The Expansion of CD25 high IL-10 high FoxP3 high B Regulatory Cells Is in Association with SLE Disease Activity. J Immunol Res \n                           2015, 254245 (2015).","journal-title":"J Immunol Res"},{"key":"14089_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/bjd.13192","volume":"172","author":"HQ Zhu","year":"2015","unstructured":"Zhu, H. Q. et al. Impaired function of CD19(+) CD24(hi) CD38(hi) regulatory B cells in patients with pemphigus. Br J Dermatol \n                           172, 101\u2013110 (2015).","journal-title":"Br J Dermatol"},{"key":"14089_CR13","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1078\/0171-2985-00198","volume":"206","author":"K Warnatz","year":"2002","unstructured":"Warnatz, K. et al. Expansion of CD19(hi)CD21(lo\/neg) B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia. Immunobiology \n                           206, 502\u2013513 (2002).","journal-title":"Immunobiology"},{"key":"14089_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10875-006-9051-1","volume":"27","author":"DA Culton","year":"2007","unstructured":"Culton, D. A. et al. Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss. J Clin Immunol \n                           27, 53\u201368 (2007).","journal-title":"J Clin Immunol"},{"key":"14089_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.clim.2007.10.004","volume":"126","author":"MW Nicholas","year":"2008","unstructured":"Nicholas, M. W. et al. A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLE. Clin Immunol \n                           126, 189\u2013201 (2008).","journal-title":"Clin Immunol"},{"key":"14089_CR16","doi-asserted-by":"publisher","first-page":"6635","DOI":"10.4049\/jimmunol.165.11.6635","volume":"165","author":"S Sato","year":"2000","unstructured":"Sato, S., Hasegawa, M., Fujimoto, M., Tedder, T. F. & Takehara, K. Quantitative genetic variation in CD19 expression correlates with autoimmunity. J Immunol \n                           165, 6635\u20136643 (2000).","journal-title":"J Immunol"},{"key":"14089_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000082087","volume":"8","author":"TF Tedder","year":"2005","unstructured":"Tedder, T. F., Poe, J. C., Fujimoto, M., Haas, K. M. & Sato, S. The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system. Curr Dir Autoimmun \n                           8, 55\u201390 (2005).","journal-title":"Curr Dir Autoimmun"},{"key":"14089_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fimmu.2012.00027","volume":"3","author":"S Chevrier","year":"2012","unstructured":"Chevrier, S., Genton, C., Malissen, B., Malissen, M. & Acha-Orbea, H. Dominant Role of CD80-CD86 Over CD40 and ICOSL in the Massive Polyclonal B Cell Activation Mediated by LAT(Y136F) CD4(+) T Cells. Front Immunol \n                           3, 27 (2012).","journal-title":"Front Immunol"},{"key":"14089_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000075685","volume":"7","author":"RH Carter","year":"2004","unstructured":"Carter, R. H. & Barrington, R. A. Signaling by the CD19\/CD21 complex on B cells. Curr Dir Autoimmun \n                           7, 4\u201332 (2004).","journal-title":"Curr Dir Autoimmun"},{"key":"14089_CR20","doi-asserted-by":"publisher","first-page":"32662","DOI":"10.1074\/jbc.274.46.32662","volume":"274","author":"LO Beitz","year":"1999","unstructured":"Beitz, L. O., Fruman, D. A., Kurosaki, T., Cantley, L. C. & Scharenberg, A. M. SYK is upstream of phosphoinositide 3-kinase in B cell receptor signaling. J Biol Chem \n                           274, 32662\u201332666 (1999).","journal-title":"J Biol Chem"},{"key":"14089_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S1074-7613(00)00007-8","volume":"13","author":"M Fujimoto","year":"2000","unstructured":"Fujimoto, M. et al. CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification. Immunity \n                           13, 47\u201357 (2000).","journal-title":"Immunity"},{"key":"14089_CR22","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1074\/jbc.M003918200","volume":"276","author":"DC Otero","year":"2001","unstructured":"Otero, D. C., Omori, S. A. & Rickert, R. C. Cd19-dependent activation of Akt kinase in B-lymphocytes. J Biol Chem \n                           276, 1474\u20131478 (2001).","journal-title":"J Biol Chem"},{"key":"14089_CR23","doi-asserted-by":"crossref","unstructured":"Xu, Y., Fairfax, K., Light, A., Huntington, N. D. & Tarlinton, D. M. CD19 differentially regulates BCR signalling through the recruitment of PI3K. Autoimmunity, 1\u20138 (2014).","DOI":"10.3109\/08916934.2014.921810"},{"key":"14089_CR24","doi-asserted-by":"publisher","first-page":"44820","DOI":"10.1074\/jbc.M107559200","volume":"276","author":"M Fujimoto","year":"2001","unstructured":"Fujimoto, M., Poe, J. C., Hasegawa, M. & Tedder, T. F. CD19 amplification of B lymphocyte Ca2+ responses: a role for Lyn sequestration in extinguishing negative regulation. J Biol Chem \n                           276, 44820\u201344827 (2001).","journal-title":"J Biol Chem"},{"key":"14089_CR25","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1084\/jem.186.11.1923","volume":"186","author":"M Inaoki","year":"1997","unstructured":"Inaoki, M., Sato, S., Weintraub, B. C., Goodnow, C. C. & Tedder, T. F. CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J Exp Med \n                           186, 1923\u20131931 (1997).","journal-title":"J Exp Med"},{"key":"14089_CR26","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/1521-4141(200102)31:2<609::AID-IMMU609>3.0.CO;2-9","volume":"31","author":"N Wehrli","year":"2001","unstructured":"Wehrli, N. et al. Changing responsiveness to chemokines allows medullary plasmablasts to leave lymph nodes. Eur J Immunol \n                           31, 609\u2013616 (2001).","journal-title":"Eur J Immunol"},{"key":"14089_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.clim.2004.05.010","volume":"113","author":"C Wehr","year":"2004","unstructured":"Wehr, C. et al. A new CD21low B cell population in the peripheral blood of patients with SLE. Clin Immunol \n                           113, 161\u2013171 (2004).","journal-title":"Clin Immunol"},{"key":"14089_CR28","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1182\/blood-2011-06-338855","volume":"118","author":"FK Stevenson","year":"2011","unstructured":"Stevenson, F. K., Krysov, S., Davies, A. J., Steele, A. J. & Packham, G. B-cell receptor signaling in chronic lymphocytic leukemia. Blood \n                           118, 4313\u20134320 (2011).","journal-title":"Blood"},{"key":"14089_CR29","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/nri955","volume":"2","author":"H Niiro","year":"2002","unstructured":"Niiro, H. & Clark, E. A. Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol \n                           2, 945\u2013956 (2002).","journal-title":"Nat Rev Immunol"},{"key":"14089_CR30","doi-asserted-by":"publisher","first-page":"e88177","DOI":"10.1371\/journal.pone.0088177","volume":"9","author":"G Assmann","year":"2014","unstructured":"Assmann, G. et al. Prevalence of anti-citrullinated protein antibodies (ACPA) in patients with diffuse large B-cell lymphoma (DLBCL): a case-control study. PLoS One \n                           9, e88177 (2014).","journal-title":"PLoS One"},{"key":"14089_CR31","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh, A. A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature \n                           403, 503\u2013511 (2000).","journal-title":"Nature"},{"key":"14089_CR32","doi-asserted-by":"publisher","first-page":"9991","DOI":"10.1073\/pnas.1732008100","volume":"100","author":"G Wright","year":"2003","unstructured":"Wright, G. et al. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci USA \n                           100, 9991\u20139996 (2003).","journal-title":"Proc Natl Acad Sci USA"},{"key":"14089_CR33","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMoa012914","volume":"346","author":"A Rosenwald","year":"2002","unstructured":"Rosenwald, A. et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med \n                           346, 1937\u20131947 (2002).","journal-title":"N Engl J Med"},{"key":"14089_CR34","doi-asserted-by":"crossref","unstructured":"Azrielant, S. et al. Correlation between systemic lupus erythematosus and malignancies: a cross-sectional population-based study. Immunol Res (2017).","DOI":"10.1007\/s12026-016-8885-8"},{"key":"14089_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.semarthrit.2008.05.002","volume":"39","author":"DE Furst","year":"2009","unstructured":"Furst, D. E. Serum immunoglobulins and risk of infection: how low can you go? Semin Arthritis Rheum \n                           39, 18\u201329 (2009).","journal-title":"Semin Arthritis Rheum"},{"key":"14089_CR36","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/jdv.12772","volume":"29","author":"M Hertl","year":"2015","unstructured":"Hertl, M. et al. Pemphigus. S2 Guideline for diagnosis and treatment\u2013guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol \n                           29, 405\u2013414 (2015).","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"14089_CR37","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3389\/fimmu.2017.00682","volume":"8","author":"W Zeng","year":"2017","unstructured":"Zeng, W. et al. Distinct Transcriptional and Alternative Splicing Signatures of Decidual CD4+ T Cells in Early Human Pregnancy. Front Immunol \n                           8, 682 (2017).","journal-title":"Front Immunol"},{"key":"14089_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/srep36560","volume":"6","author":"W Zeng","year":"2016","unstructured":"Zeng, W. et al. Characterization of T follicular helper cells in allogeneic normal pregnancy and PDL1 blockage-induced abortion. Sci Rep \n                           6, 36560 (2016).","journal-title":"Sci Rep"},{"key":"14089_CR39","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/cmi.2014.16","volume":"11","author":"W Zeng","year":"2014","unstructured":"Zeng, W. et al. Long-term exposure to decabrominated diphenyl ether impairs CD8 T-cell function in adult mice. Cell Mol Immunol \n                           11, 367\u2013376 (2014).","journal-title":"Cell Mol Immunol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14089-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14089-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14089-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T07:36:47Z","timestamp":1671781007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14089-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,24]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["14089"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-14089-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,24]]},"assertion":[{"value":"16 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13921"}}